The institute considered 2,608 individual ratings across seven areas, including products and services, innovation, workplace, governance, citizenship, leadership and financial performance. The institute combined the scores into a RepTrak score. Overall, the industry saw a 3.7 percent decrease in reputation scores from 2017.
Here are where nine pharmaceutical companies with a GI presence ranked, along with their RepTrak score:
2. Genentech: 74
3. Celgene: 72.5
4. AbbVie: 72.3
6. Bayer: 70.7
8. Allergan: 69.8
10. McKesson: 68.7
16. AstraZeneca: 64.3
18. Takeda: 61.6
20. Merck: 58.4
To view the whole list, click here.
More articles on gastroenterology:
Ex-Tenet executive claims kickback charges ‘legally flawed’ — 5 insights
Primary care beats surgical organizations in safe injection practices — 4 quick facts
Driving change in outpatient spine surgery: Q&A with Laser Spine Institute CEO Roger Cary
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
